BIOSPAIN 2026

Dr. Bueren leads the Biomedical Innovation Unit at CIEMAT and also conducts research at CIBERER and the Jiménez Díaz Foundation Health Research Institute. Throughout his career, he has made decisive contributions to the development of new gene and cell therapies targeting rare and hereditary diseases, driving the translation of research from the laboratory to clinical practice.

Internationally recognized for his scientific contributions and leadership in the field of gene therapy, he has also served as president of the European Society for Gene and Cell Therapy, promoting the advancement and accessibility of these innovative therapies for patients.

At BIOSPAIN, he will will share an updated perspective on the advances transforming the treatment of rare diseases, as well as the scientific, regulatory, and access challenges that still need to be overcome to ensure these therapies reach all patients who need them.

1. Conselleiro de Educación, Ciencia, Universidades y FP (Nota: Este seria nuestro Conselleiro, es donde esta integrada la Agencia Gallega de Innovación(GAIN))
Román Rodríguez González
Mails:
[email protected] (Conselleiro de Educación, Ciencia, Universidades y FP)
[email protected] (Jefe Gabinete Conselleiro)
[email protected] (Secretaria Conselleiro)
2. Conselleiro de Sanidad
Antonio Gómez Caamaño
Mails:
[email protected] (Conselleiro de Sanidad)
[email protected] (Jefa Gabinete Conselleiro)
[email protected] (Secretaria Conselleiro)

Regional biotechnology clusters and associations play a vital role in strengthening the biotechnology ecosystem by promoting collaboration among stakeholders, facilitating knowledge transfer, and accelerating the scientific and business development of the sector. Their work enhances the competitiveness of biotechnology companies while reinforcing the innovation and growth potential of their respective regions.

The aim of this session is to examine the role of biotechnology clusters in the development of the sector, explore how they collaborate with one another, and identify the key strengths and challenges across different regions, highlighting both shared priorities and the distinctive characteristics of each regional ecosystem. The discussion will also address the Biotech Act proposal to promote networks of biotechnology clusters as a means of strengthening competitiveness and fostering collaboration across the European biotechnology sector.

Propuesta de Ponentes: 

Moderador: Acesabio o bien AseBio y metemos a Acesabio como ponente?

• Idoia Muñoz, Directora del BHC
• Robert Fabregat, Director general de Biocat
• Jesús Agüero, Director Bioval
• Zara Pons, General Manager BIOIB
• Loli Pereiro, Manager Bioga